Virus News and Research

Latest Virus News and Research

Bird flu investigator says continuation of research remains 'urgent' despite moratorium

Research into transmissible bird flu strains remains "urgent" despite flu investigators' recent declaration of a "60-day moratorium on avian flu transmission because of the current controversy," Yoshihiro Kawaoka of Tokyo University and the University of Wisconsin-Madison, "a lead researcher on one of two recent studies showing how H5N1 can be transmitted through airborne droplets" among ferrets, writes in a commentary published Wednesday in the journal Nature, Reuters reports.

27 Jan 2012

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Research to Prevent Blindness (RPB) has granted Massachusetts Eye and Ear Infirmary cornea specialist James Chodosh, M.D., M.P.H., a $150,000 Senior Scientific Investigator Award. RPB Senior Scientific Investigator Awards support nationally recognized scientists conducting eye research at medical institutions in the United States.

27 Jan 2012

Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

Boehringer Ingelheim announced today the initiation of two phase III clinical trials, LUX-Head & Neck 1 and LUX-Head & Neck 2. These trials evaluate afatinib in patients with metastatic and recurrent head and neck cancer, and in patients with locally advanced disease, respectively.

27 Jan 2012

Universal access to HIV treatment can be achieved

"Thirty years after AIDS made its deadly debut, a future without the disease is finally within reach," a Boston Globe editorial states, adding, "But just as science is on the verge of winning the battle, financial resources and political will are flagging."

25 Jan 2012

OraQuick HIV1/2 test as accurate as traditional blood test

A saliva test used to diagnose the human immunodeficiency virus (HIV), is comparable in accuracy to the traditional blood test, according to a new study led by the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.

25 Jan 2012

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience, a French company focused on viral disease therapeutics, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.

24 Jan 2012

Gilead commences GS-7340 Phase 2 trial in HIV

Gilead Sciences, Inc. today announced the initiation of a Phase 2 clinical trial evaluating GS-7340 for the treatment of HIV-1 infection in treatment-naïve adults. GS-7340 is a novel prodrug of tenofovir, the active agent in Viread.

24 Jan 2012

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.

24 Jan 2012

Cholesterol receptor allows entry of HCV virus into human liver cells

A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine.

24 Jan 2012

Voluntary action by two research teams to halt work on H5N1 lauded

A Georgetown University Medical Center professor says the voluntary action taken by two research teams to temporarily halt work involving the highly pathogenic avian influenza H5N1 is "laudable."

24 Jan 2012

Settling controversy surrounding bird flu research will not be easy

The WHO is expected to hold a meeting in February to discuss controversy over recent research on the H5N1 bird flu virus, after the U.S. National Scientific Advisory Board for Biosecurity (NSABB) in December advised the journals Science and Nature to withhold publishing two teams' research on the virus for fear the information could "fall into the wrong hands," a commentary in the Economist's "Babbage" blog states.

24 Jan 2012

New gene therapy shows promise against X-linked retinitis pigmentosa

A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.

24 Jan 2012

Scientists halt bird flu research for 60 days amid safety concerns

The head of the NIH National Institute of Allergy and Infectious Diseases (NIAID), which funded "two projects that created a highly pathogenic [H5N1] flu virus mutation, has welcomed a two-month moratorium on further research while defending the value and safety of the experiments," the Financial Times reports.

24 Jan 2012

China releases updated statistics on HIV/AIDS

"A total of 28,000 people died of HIV/AIDS in China in 2011, and another 48,000 in the country were found newly infected by the virus, according to an official publication" released on Saturday by China's Ministry of Health, UNAIDS, and the WHO, Xinhua/China Daily reports.

24 Jan 2012

Duke team creates vaccine adjuvant of nanoparticles that target lymph nodes

Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, Ph.D., a researcher at Duke-NUS Graduate Medical School.

23 Jan 2012

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.

21 Jan 2012

Debate over publication of bird flu studies continues in journal opinion pieces

Ron Fouchier of Erasmus Medical Center in the Netherlands -- lead researcher of one of two teams that last year reported study results "that showed how the H5N1 [bird flu] virus can be transmitted through airborne droplets between ferrets, a model for studying influenza in humans."

21 Jan 2012

FDA allows marketing of Stratify JCV Antibody ELISA test for PML

Today, the U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a rare brain infection called progressive multifocal leukoencephalopathy (PML) in people using the drug Tysabri (natalizumab) to treat multiple sclerosis (MS) or Crohn's disease.

21 Jan 2012

FDA approves product label change for Biogen Idec's TYSABRI to treat MS

Today Biogen Idec and Elan Corporation, plc announced that the U.S. Food and Drug Administration (FDA) has approved a product label change for TYSABRI that will help enable individual benefit risk assessment for patients with multiple sclerosis.

21 Jan 2012

More than half of high-risk Americans do not receive HBV vaccination

Although there is an effective vaccine for hepatitis B and public health officials have a strong sense of who is at highest risk for the infectious liver disease, tens of thousands of people in the United States contract the virus every year. According to a new study by researchers at Brown University, missed opportunities to administer the vaccine continue to be a reason why infections persist.

20 Jan 2012